Drax Group PLC
OTC:DRXGY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Drax Group PLC
OTC:DRXGY
|
UK |
|
C
|
Clarity Pharmaceuticals Ltd
OTC:CLRPF
|
AU |
|
S
|
Solis Holdings Ltd
HKEX:2227
|
SG |
|
S
|
Signify NV
F:G14
|
NL |
Wall Street
Price Targets
DRXGY Price Targets Summary
Drax Group PLC
According to Wall Street analysts, the average 1-year price target for
DRXGY
is 26.94 USD
with a low forecast of 20.13 USD and a high forecast of 32.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DRXGY's stock price target?
Price Target
26.94
USD
According to Wall Street analysts, the average 1-year price target for
DRXGY
is 26.94 USD
with a low forecast of 20.13 USD and a high forecast of 32.55 USD.
What is Drax Group PLC's Revenue forecast?
Projected CAGR
-5%
For the last 14 years the
compound annual growth rate for
Drax Group PLC's revenue is
8%.
The projected
CAGR
for the next 3 years is
-5%.
What is Drax Group PLC's Operating Income forecast?
Projected CAGR
-22%
For the last 14 years the
compound annual growth rate for
Drax Group PLC's operating income is
7%.
The projected
CAGR
for the next 3 years is
-22%.
What is Drax Group PLC's Net Income forecast?
Projected CAGR
44%
For the last 14 years the
compound annual growth rate for
Drax Group PLC's net income is
-12%.
The projected
CAGR
for the next 3 years is
44%.
